May 2026: Thirlwall Inquiry report delayed to at least September 2026 · six-baby inquests relisted to 2027 · CCRC review active · Shoo Lee Panel: no medical evidence of deliberate harm.
Outcome: Survived
Gestation: Preterm twin
Sensitivity note: court-imposed lifelong anonymity covers every family. We use the court-assigned code only. See our families and witnesses sensitivity policy.
Insulin in feeds.
Method alleged: Exogenous insulin administered in enteral feeds.
Prosecution experts: Prof. Peter Hindmarsh (UCL / Great Ormond Street); Royal Liverpool biochemists.
Panel / endocrinologists: unreliable screening immunoassay; no confirmation.
No fatal outcome — no post-mortem. Screening insulin immunoassay result from Royal Liverpool clinical biochemistry laboratory was the primary evidential basis for the count. No confirmatory mass-spectrometry testing was performed. The Roche Cobas immunoassay is prone to interference from maternal insulin auto-antibodies, particularly in the Type 1 diabetes maternal context (Baby L's mother had T1 diabetes and the auto-antibody transfer window is longer than in gestational diabetes). The Baby F insulin evidence entry (separate record) addresses the same assay architecture applied to Baby F; the Joint Expert Witness Insulin Report on Babies F and L (May 2025) is the authoritative post-conviction document on both counts.
Read the full long-form analysis →
Sources:
This page uses only the court-assigned code and publicly reported facts. The court imposed lifelong anonymity on every family; this site does not contact families and does not speculate about private circumstances.